SAISSY KENDIG: Open Payments
NPI 1811418619 · MIDDLEBURG HEIGHTS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 22 payments from 11 companies in 2025. Trend: 2023 $308 · 2024 $730 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Alkermes, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Sage Therapeutics, LLC | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $18 |
Products named: REXULTI, VRAYLAR, INGREZZA, COBENFY, TRINTELLIX, ZURZUVAE, Qelbree, HETLIOZ.
Industry payments across OH — which companies pay providers there.
